01 4GLAXO GRP ENGLAND
02 35GLAXOSMITHKLINE
01 47439393
02 47488827
03 47498440
04 58183257
05 48309572
06 18511304
07 28534281
08 28746242
09 39750726
10 211090294
11 37439393*PED
12 18511304*PED
13 28534281*PED
14 28746242*PED
01 12Y
02 27Blank
01 20Y
02 19Blank
01 82025-04-27
02 42025-05-21
03 52025-07-27
04 32025-11-21
05 12027-06-14
06 12027-12-14
07 42027-12-18
08 22030-03-08
09 22030-09-08
10 22030-10-11
11 52030-11-29
12 22031-04-11
Patent Expiration Date : 2025-07-27
US Patent Number : 8183257
Drug Substance Claim :
Drug Product Claim :
Application Number : 205382
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-07-27
Patent Expiration Date : 2025-04-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-04-27
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 205382
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-04-27
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-07-27
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8183257
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-07-27
Patent Expiration Date : 2030-11-29
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 11090294
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-3202
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-29
Patent Expiration Date : 2030-11-29
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 11090294
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-3203
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-29
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209482
Patent Use Code : U-2127
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2025-07-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8183257
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2128
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-07-27
Patent Expiration Date : 2025-04-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-27
